Overview


According to FutureWise analysis the market for animal blood plasma products and derivatives is expected to register a CAGR of 7.32% from 2023-2031.

Animal plasma refers to the liquid component of blood obtained from animals. It is similar in composition to human blood plasma and is crucial in various medical, pharmaceutical, and research applications. Animal plasma contains proteins, electrolytes, hormones, antibodies, and other vital substances necessary for normal bodily functions. It contains clotting factors that help in the coagulation process, immunoglobulins that play a key role in the immune response, and albumin, which helps maintain osmotic pressure in the blood. Animal blood plasma products and derivatives refer to various substances derived from the blood plasma of animals. These specialized products find wide-ranging applications in the fields of medicine, pharmaceuticals, cosmetics, sports, and scientific research. Comprising various proteins, antibodies, clotting factors, and other essential components, these derivatives serve as critical tools in clinical and laboratory settings.

Serum albumin is a protein in blood plasma that helps regulate osmotic pressure, which balances fluid exchange between blood vessels and tissues. It comprises approximately 55 percent of the total protein in blood plasma. They transport protein, scavenge free radicals, and regulate osmotic pressure when circulating blood tends to exert pressure fluid out of the blood vessels and into the tissues, resulting in edema or swelling. The colloidal nature of albumin and other blood proteins called globulins helps retain fluid within blood vessels. Moreover, albumin also acts as a carrier for two essential components for the control of blood clotting: antithrombin, which keeps the clotting enzyme thrombin from working unless needed, and heparin cofactor, which is necessary for the anticoagulant action of heparin. In instances of liver disorders like cirrhosis or hepatitis, the levels of serum albumin can fluctuate, indicating the impact of such conditions on this vital blood protein.

FutureWise Market Research has published a report that provides an insightful analysis animal blood plasma products and derivatives market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal blood plasma products and derivatives market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Lake Immunogenics
  • Auckland Biosciences
  • KraeberCo. Gmbh
  • Sigma-aldrich
  • Thermo Fisher Scientific
  • Rocky Mountain Biologicals
  • Lampire Biological Laboratories
  • Bovogen Biologicals
  • Proliant
  • Anzco Foods

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Immunoglobulin
  • Fibrinogen
  • Serum Albumin
  • Fetal Bovine Serum

By Application

  • Cell Culture Media
  • Food Industry
  • Pharmaceutical Industry
  • Sports Nutrition
  • Nutrition Supplements
  • Cosmetic Industry
  • Diagnostic Industry
  • Pet Food Industry

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Animal Blood Plasma Products and Derivatives Market By Product, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Blood Plasma Products and Derivatives Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Blood Plasma Products and Derivatives Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Blood Plasma Products and Derivatives Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Blood Plasma Products and Derivatives Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunoglobulin
        2. Fibrinogen
        3. Serum Albumin
        4. Fetal Bovine Serum

  • 8.   Animal Blood Plasma Products and Derivatives Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cell Culture Media
        2. Food Industry
        3. Pharmaceutical Industry
        4. Sports Nutrition
        5. Nutrition Supplements
        6. Cosmetic Industry
        7. Diagnostic Industry
        8. Pet Food Industry

  • 9.   North America Animal Blood Plasma Products and Derivatives Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Animal Blood Plasma Products and Derivatives Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Animal Blood Plasma Products and Derivatives Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Animal Blood Plasma Products and Derivatives Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Lake Immunogenics
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Auckland Biosciences
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. KraeberCo. Gmbh
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Sigma-aldrich
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Thermo Fisher Scientific
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Rocky Mountain Biologicals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Lampire Biological Laboratories
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bovogen Biologicals
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Proliant
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Anzco Foods
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Blood Plasma Derivatives Market

Read More

Bovine Blood Plasma Derivatives Market

Read More
Partner

Our Clients